SFRP1 and gastric cancer: MiR-196a could promote the invasion and metastasis of gastric cancer by targeting SFRP1; miR-383-5p was downregulated and might act as a tumor suppressor for gastric cancer, and miR-374a has been reported to act as a biomarker for the diagnosis and prognosis of gastric cancer [12–14].